ArticleFrontiers in immunology2023

Mid-titer human convalescent plasma administration results in suboptimal prophylaxis against SARS-CoV-2 infection in rhesus macaques.

Brandon J Beddingfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.